E-drug: Registration of generic misoprostol (cont)
-------------------------------------------
Canadian policy is that the company has to apply for registration of a
drug. The drug regulatory authority does not initiate registration. I'm
not really sure how this policy developed.
Joel
Joel Lexchin MD
121 Walmer Rd.
Toronto, Ontario
CANADA M5R 2X8
Phone: (416)-964-7186
Fax: (416)-923-9515
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.